What's Happening?
The International Service for the Acquisition of Agri-biotech Applications (ISAAA) has introduced corporate subscriptions for its comprehensive biotech industry reports. The newly released ISAAA Brief
57 provides a detailed analysis of the global status of commercialized biotech/GM crops in 2024, offering insights into market trends and regulatory landscapes. The report, backed by 29 years of data, serves as a strategic tool for organizations to anticipate market shifts and navigate approval processes. Subscription plans are available for small teams, corporate groups, and institutions, providing access to expert recommendations and strategic insights.
Why It's Important?
In the rapidly evolving biotech industry, access to reliable data and strategic insights is crucial for organizations to maintain a competitive edge. The ISAAA's corporate subscriptions offer valuable resources for stakeholders to identify emerging markets, understand the research pipeline, and accelerate time-to-market for new biotech traits. This initiative supports industry growth by equipping teams with the knowledge needed to drive innovation and adapt to regulatory changes, ultimately benefiting the global agri-biotech sector.
